Particles that enhance mRNA delivery could reduce vaccine dosage and costs
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
Cultured from induced pluripotent stem cells, “miBrains” integrate all major brain cell types and model brain structures, cellular interactions, activity, and pathological features.
MIT researchers created microscopic wireless electronic devices that travel through blood and implant in target brain regions, where they provide electrical stimulation.
MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.
Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.
Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.
Professors Michael McDonald and Kristala Prather are honored as “Committed to Caring.”
The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.
Proposed system would combine two kinds of plants, creating greater efficiency and lowering costs while curbing climate-changing emissions.
MIT researchers developed a model that explains lithium intercalation rates in lithium-ion batteries.
MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders.
New findings could provide a way to monitor batteries for sounds that could guide manufacturing, indicate remaining usable life, or flag potential safety issues.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
System developed at MIT could provide realistic predictions for a wide variety of reactions, while maintaining real-world physical constraints.
Brushett leads one-of-its-kind program that has been a bridge between education and industry for over a century.